HTT and Huntington disease: We demonstrate here that calcineurin is dysregulated in Huntington's disease and that the pharmacological and genetic inactivation of calcineurin leads to an increase in the phosphorylation of mutant huntingtin at S421, resulting in the restoration of its function in the intracellular transport of BDNF within cortical neurons.